Cleo Life Sciences

Executive Summary

Cleo Life Sciences is a privately held pharmaceutical consulting firm based in South San Francisco, founded in 2004. The company specializes in Chemistry, Manufacturing, and Controls (CMC) advisory services and operates a small-scale R&D prototyping lab for pharmaceutical formulation development. By enabling nimble prototyping with reduced API quantities, Cleo supports clients in initiating formulation development earlier in the drug development cycle, potentially reducing time and cost. As a niche service provider in a critical area of drug development, Cleo Life Sciences benefits from the increasing outsourcing of CMC activities by biotech and pharma companies. However, its position as a consulting firm with limited scalability may constrain growth. The company's long track record since 2004 suggests stability and expertise, but lack of public information on financials or pipeline limits further assessment.

Upcoming Catalysts (preview)

• TBDExpansion of prototyping lab capabilities or capacity70% success
• Q4 2026Major strategic partnership or contract win with a mid-to-large pharma company60% success
• Q2 2026Release of new service offerings (e.g., specialized formulation for biologics or gene therapies)50% success